Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Apr;15(2):124-32.
doi: 10.1111/j.1750-3639.2005.tb00507.x.

New roles for galectins in brain tumors--from prognostic markers to therapeutic targets

Brianna N Stillman  1 , Paul S Mischel, Linda G Baum
Affiliations
Review

New roles for galectins in brain tumors--from prognostic markers to therapeutic targets

Brianna N Stillman et al. Brain Pathol. 2005 Apr.

Abstract

Despite advances in diagnosis and treatment, brain tumors continue to be the leading cause of cancer-related death in patients under 35 years of age, demonstrating the need for better prognostic and therapeutic targets. Galectins, a family of mammalian carbohydrate binding proteins, are involved in many processes important for tumor survival and dissemination, including proliferation, apoptosis, transcriptional regulation, intracellular signaling, cell adhesion, and cell migration. Several galectins are expressed in human brain, with many galectins demonstrating altered expression during tumor progression. Thus, galectins and the functions regulated by this family of proteins are potential targets for the diagnosis and treatment of brain cancer. This review highlights the roles of galectins in cancer and specifically, the developing field of galectins in brain cancer.

PubMed Disclaimer

References

    1. Ahmad N, Gabius HJ, Andre S, Kaltner H, Sabesan S, Roy R, Liu B, Macaluso F, Brewer CF (2004) Galectin‐3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross‐linked complexes. J Biol Chem 279:10841–10847. - PubMed
    1. Ahmad N, Gabius HJ, Sabesan S, Oscarson S, Brewer CF (2004) Thermodynamic binding studies of bivalent oligosaccharides to galectin‐1, galectin‐3, and the carbohydrate recognition domain of galectin‐3. Glycobiology 14:817–825. - PubMed
    1. Akahani S, Nangia‐Makker P, Inohara H, Kim HR, Raz A (1997) Galectin‐3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl‐2 family. Cancer Res 57:5272–5276. - PubMed
    1. Allen HJ, Sharma A, Ahmed H, Piver MS, Gamarra M (1993) Galaptin and galaptin‐binding glycoconjugates in serum and effusions of carcinoma patients. Tumour Biol 14:360–368. - PubMed
    1. Allione A, Wells V, Forni G, Mallucci L, Novelli F (1998) Beta‐galactoside‐binding protein (beta GBP) alters the cell cycle, up‐regulates expression of the alpha‐ and beta‐chains of the IFN‐gamma receptor, and triggers IFN‐gamma‐mediated apoptosis of activated human T lymphocytes. J Immunol 161:2114–2119. - PubMed

Publication types